Prevention of thromboembolism after hip fracture.
D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001458:Bandages; D003374:Coumarins / Q000627:therapeutic use; D003911:Dextrans / Q000627:therapeutic use; D005081:Exercise Therapy; D005265:Femoral Neck Fractures / Q000401:mortality / Q000601:surgery; D005340:Fibrinogen; D050723:Fractures, Bone / Q000601:surgery*; D006470:Hemorrhage / Q000453:epidemiology; D025981:Hip Injuries; D006801:Humans; D007456:Iodine Isotopes; D005082:Physical Exertion; D011182:Postoperative Care; D011183:Postoperative Complications / Q000517:prevention & control*; D011655:Pulmonary Embolism / Q000517:prevention & control; D013923:Thromboembolism / Q000517:prevention & control*; D013924:Thrombophlebitis / Q000517:prevention & control; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D003374:Coumarins; D003911:Dextrans; D007456:Iodine Isotopes; D014859:Warfarin; D005340:Fibrinogen; D001241:Aspirin